<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40351">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02125123</url>
  </required_header>
  <id_info>
    <org_study_id>AL15</org_study_id>
    <nct_id>NCT02125123</nct_id>
  </id_info>
  <brief_title>Oral Nutritional Supplementation in Children</brief_title>
  <official_title>Oral Nutritional Supplementation in Children With Picky Eating Behaviors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effect of an oral nutritional supplement (ONS) along with
      dietary counseling on improving the dietary intake among children with picky eating
      behaviors.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Vitamin D Intake</measure>
    <time_frame>Change from Baseline to Week 4</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Macronutrient Intake</measure>
    <time_frame>Change from Baseline to Week 4</time_frame>
    <safety_issue>No</safety_issue>
    <description>24-hour dietary recall interview</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micronutrient Intake</measure>
    <time_frame>Change from Baseline to Week 4</time_frame>
    <safety_issue>No</safety_issue>
    <description>24-hour dietary recall interview</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Nutritional Supplement and Counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two servings a day; ready-to-feed nutritional supplement plus dietary counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Counseling</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Supplement and Counseling</intervention_name>
    <description>Ready-to-feed nutritional supplement and dietary counseling</description>
    <arm_group_label>Nutritional Supplement and Counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Counseling</intervention_name>
    <description>Dietary counseling</description>
    <arm_group_label>Counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. â‰¥ 48 months and &lt; 73 months of age.

          2. Healthy and not suffering from any physical disability.

          3. Height-for-age and BMI-for-age between the 5th and the 95th percentile;
             weight-for-age between the 5th and the 85th percentile.

          4. Capable of oral feeding.

          5. Has a mean score of greater than 3.0 on the fussiness category in the Children's
             Eating Behaviour Questionnaire.

          6. Willing to abstain from consuming non-study nutritional supplements during the study
             intervention period.

        Exclusion Criteria:

          1. History of an acute or chronic condition that may affect feeding habits or
             nutritional status.

          2. Taking any medications or nutritional supplements on a daily basis for more than 2
             weeks during the past month that may profoundly affect feeding habits or nutritional
             status.

          3. Clinically significant nutritional deficiency requiring specific treatment with any
             other nutritional supplement.

          4. Any acute/chronic condition requiring medical treatment which may include
             hospitalization.

          5. Allergy or intolerance to any ingredient in the study product.

          6. Gastrointestinal infection, acute constipation or acute diarrhea.

          7. Hepatitis B or C, or HIV, or malignancy.

          8. Congenital cardiac defects.

          9. Dysphagia, aspiration risk or difficulty in swallowing due to acquired/congenital
             abnormalities.

         10. Parent(s)/LG of the subject has any clinically significant medical disease or
             physical/psychological condition that may interfere with protocol adherence or
             ability of the parent(s)/LG to give informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>48 Months</minimum_age>
    <maximum_age>73 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Williams, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radiant Research, Inc.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Michael J Noss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>April 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
